Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II StudyAndrew B. Lassman, Patrick Roth, Filip De Vos et al.|Zurich Open Repository and Archive (University of Zurich)|2022Cited by 76
ACTR-33. INFIGRATINIB (BGJ398) IN PATIENTS WITH RECURRENT GLIOMAS WITH FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) ALTERATIONS: A MULTICENTER PHASE II STUDYAndrew B. Lassman, Patrick Roth, Juan Manuel Sepúlveda-Sánchez et al.|Neuro-Oncology|2019Cited by 8
Supplementary Figure from Infigratinib in Patients with Recurrent Gliomas and <i>FGFR</i> Alterations: A Multicenter Phase II StudyAndrew B. Lassman, Patrick Roth, Juan Manuel Sepúlveda-Sánchez et al.|Unknown|2023Cited by 0